Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Nestlé
Pharma
Palforzia gets new owner as Nestlé ditches peanut allergy drug
Nestlé has resold the peanut allergy drug Palforzia, which it originally bought in 2020 in a $2 billion-plus acquisition.
Angus Liu
Sep 5, 2023 11:20am
Nestle Health nabs Pfizer, Meta veteran for chief marketing role
Aug 23, 2023 10:30am
FDA approves first oral microbiome therapy from Nestlé, Seres
Apr 26, 2023 6:12pm
Nestlé lays out $2.1B for peanut allergy drugmaker Aimmune
Aug 31, 2020 10:27am
Deal-minded AbbVie, Allergan sell 3 meds to AZ and Nestlé
Jan 27, 2020 10:56am
Ex-Shire CEO Ornskov emerges as Galderma chief after Nestlé spin
Oct 8, 2019 11:42am
